Agenus Inc. has grown revenue 10% a year over three years and 14% a year over five. Revenue growth, 3-year annual rate: +10% (Biotechnology median +17%). Revenue growth, 5-year rate: +14%, growth has slowed since the five-year average. Years of annual history on file: 17, FY2009 to FY2025, as filed.

AGENAgenus Inc.

Healthcare

$3.03-39% 1Y

$3.03

$2.7752 weeks$9.93

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +30% year on year and operating margin widening (+111.7 points), but earnings down −137% year on year.

2 good, 1 to watch

Revenue trend+30% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +14% a year.

Earnings trend−137% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+111.7 points operating

Trailing-twelve-month operating margin, 26.1% now against -85.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is AGEN growing?

Agenus Inc. has grown revenue 10% a year over three years and 14% a year over five.

+10%

Revenue growth, 3-year annual rate · Biotechnology median +17% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +14%
Revenue growth, 5-year rate · +10% over three · growth has slowed since the five-year average
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›